AHPA keeps members and the industry informed of recent news and developments that impact the trade through email alerts. Subscribe to news as it happens or a weekly summary of all alerts.
View recent alerts:
Subscribe to AHPA Updates to stay informed about the latest AHPA news and resources.
This issue of the IADSA Newsflash covers Australia TGA reclassifies certain sports supplements to be regulated as medicines, South Africa down scheduled CBD to a category of complementary medicine, Korea has updated its functional food code to include ginseng as helpful to bone health and the European Commission (EC) acknowledges the potential to consider traditional use of botanicals in the efficacy assessment of health claims when traditional medicine products exist for botanicals used in foods.
Webinar presenters will address different approaches to sustainability self-assessment, discuss various sustainability standards, and how to create realistic science based targets, and present examples that will help companies of all sizes plan and execute meaningful self-assessments.
AHPA continues to expand and update the online Botanical Safety Handbook 2nd ed. to provide the herbal industry with comprehensive safety information on over 500 species of herbs from clinical trials, pharmacological and toxicological studies, medical case reports, and historical texts.
It is with profound sadness that we announce the passing of our dear colleague and friend Tony Hayes. Tony was a producer and marketer of North American wildcrafted herbs for almost 50 years. He began his career in 1973 as an herb buyer for Lowe Fur and Herb of North Wilkesboro, then in 1981 went to work for Wilcox Drug Company in Boone, North Carolina. In 2000 he and his wife Sandy started their own business, Ridge Runner Trading Company.
Webinar presenters explain ways to ensure your marketing claims for herbal immune support products are substantiated, truthful and not misleading. Industry experts review several methods they’ve used to ensure their dietary supplement product claims are well substantiated, including: randomized, controlled clinical trials on a well-known elderberry product; in vitro testing to support the legitimacy of the product; and the relevance of use and training in substantiating the effectiveness of traditional Chinese herbal formulations.
Since the first week of March, the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have been issuing warning letters alleging that marketers promoted a wide variety of products with claims to prevent, treat, mitigate, diagnose or cure COVID-19.
AHPA has analyzed 135 COVID-19 related warning letters issued by either FDA or FTC or by the agencies jointly between March 6, 2020, and May 11, 2020, and made available in each agency’s coronavirus information center as of May 15, 2020.
This free webinar provides practical information on how best to resume post-quarantine business operations while protecting your workforce. Learn what personal protective equipment and workspace adaptations should be implemented and how to manage ongoing business risks and liabilities. Additionally, hear from experts about how to be proactive and search for, and then correct, workplace conditions that could increase risk of COVID-19 infections.
2021 Annual Fund Sponsors
AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.